Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01874665
Title A Phase 2 Trial of Ponatinib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Ariad Pharmaceuticals

gastrointestinal stromal tumor



Age Groups:
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital, Site #047 Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute, Site #008 Boston Massachusetts 02215 United States Details
Oregon Health & Sciences University, Site #048 Portland Oregon 97239 United States Details
Fox Chase Cancer Center, Site #012 Philadelphia Pennsylvania 19111 United States Details
*Shaded cells indicate that there was no data available from for the field